Strategic partnerships Theragenics actively engages in large-scale manufacturing collaborations, exemplified by the copper-64 supply agreement with Clarity Pharmaceuticals at its Georgia facility. This indicates a potential channel for co-development opportunities, contract manufacturing, and long-term isotope supply arrangements.

Clinical engagement The company participates in major prostate cancer-related events and workshops (LUGPA Global Prostate Cancer Congress, International Prostate Cancer Update, ABS GYN and Prostate Brachytherapy Hands-On workshop). These venues present ready-made opportunities to connect with radiopharmaceutical researchers, clinicians, and procurement teams for trials, education programs, and equipment or material needs.

Education and patient focus Recent launches of Life After Seeds resources and patient education materials signal a willingness to invest in patient support infrastructure. This opens upsell paths for supplementary services, patient engagement platforms, training, and post-treatment support solutions that align with LDR brachytherapy workflows.

Productive scale With a sizeable production footprint (134,000-square-foot facility) and revenue in the mid-range of the sector, Theragenics presents opportunities for expansion of isotope production capacity, logistics optimization, and SAP/Sage-enabled supply chain enhancements to support growing demand and faster time-to-treatment.

Radiopharmaceutical ecosystem Theragenics’ focus on radioisotopes essential for radiopharmaceuticals and LDR brachytherapy points to cross-sell opportunities with imaging centers, distribution partners, and oncology centers seeking reliable isotope supply, technical support, and compliant, end-to-end radiopharma solutions.